People: Ligand Pharmaceuticals Inc (LGND.OQ)
23 Apr 2018
Mr. Sunil Patel is Independent Director of the Company. He has more than 20 years of senior management and R&D experience in the biotechnology industry and is currently Chief Financial Officer, Senior Vice President Corporate Development & Finance for OncoMed Pharmaceuticals, a development-stage company focused on therapeutics targeting cancer stem cells. Mr. Patel has held senior management positions in corporate development, marketing, and strategy with BiPar Sciences, Allos Therapeutics, Connetics, Abgenix and Gilead Sciences. Mr. Patel also worked at McKinsey & Company serving biotech and pharmaceutical clients and has held scientific research positions at ZymoGenetics and ProCyte. Mr. Patel received his undergraduate degree in Chemistry at the University of California, Berkeley, and master’s degree in Molecular Bioengineering/Biotechnology at the University of Washington.
|Total Annual Compensation, USD||--|
|Restricted Stock Award, USD||74,205|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||195,701|
|Fiscal Year Total, USD||269,906|